Watchlist Price Alert

ArriVent BioPharma Inc. C... (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

19.55

-0.60 (-2.98%)

At close: May 12, 2025, 11:26 AM

ArriVent BioPharma Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Net Income	-20.63M	-20.56M	-21.87M	-17.42M	-21.19M	-14.4M	-21.57M	-12.17M	-10.44M	-11.77M	-7.35M	-7.35M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	952K	866K	765K	625K	319K	217K	193K	166K	113K	113K	99K	99K
Other Working Capital	4.39M	2.52M	2.37M	-1.46M	5.67M	972K	9.07M	-4.5M	-5.58M	-466K	-1.95M	-1.95M
Other Non-Cash Items	n/a	n/a	n/a	999K	24K	2.45M	-3.5M	546K	94K	2.19M	293K	293K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.53M	3.35M	2.02M	-1.84M	5.96M	-1.26M	12.77M	-4.88M	-5.56M	-466K	-1.95M	-1.95M
Operating Cash Flow	-16.15M	-16.34M	-19.09M	-18.63M	-14.91M	-15.44M	-8.61M	-16.88M	-15.89M	-9.93M	-8.91M	-8.91M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-194.16M	n/a	n/a	n/a	n/a	n/a	-25M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.7M	n/a	n/a	n/a	25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-192.47M	n/a	n/a	n/a	25M	n/a	-25M	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	55K	531K	44K	1K	-1.06M	-1.03M	4K	26K	15K	n/a	30M	30M
Financial Cash Flow	55K	531K	363K	185.63M	-1.06M	-1.03M	-20K	44.97M	109.72M	n/a	30M	30M
Net Cash Flow	-208.56M	-15.81M	-18.72M	167M	9.03M	-16.48M	-33.63M	28.09M	93.83M	-9.93M	79.46M	n/a
Free Cash Flow	-16.15M	-16.34M	-19.09M	-18.63M	-14.91M	-15.44M	-8.61M	-16.88M	-15.89M	-9.93M	-8.91M	-8.91M